We are live on ! Find out more

499 hedge funds and large institutions have $7.18B invested in Chemours in 2017 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 131 increasing their positions, 173 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more first-time investments, than exits

New positions opened: 84 | Existing positions closed: 40

32% more capital invested

Capital invested by funds: $5.42B → $7.18B (+$1.76B)

14% more call options, than puts

Call options by funds: $114M | Put options by funds: $100M

8% more funds holding

Funds holding: 462499 (+37)

0.79% less ownership

Funds ownership: 77.51%76.72% (-0.79%)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

24% less repeat investments, than reductions

Existing positions increased: 131 | Existing positions reduced: 173

Holders
499
Holders Change
+37
Holders Change %
+8.01%
% of All Funds
12.44%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.12%
New
84
Increased
131
Reduced
173
Closed
40
Calls
$114M
Puts
$100M
Net Calls
+$14M
Net Calls Change
-$827K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$916M -$20M -424,055 -2%
BlackRock
2
BlackRock
New York
$774M -$18.5M -392,913 -3%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$749M -$48.4M -1,026,597 -6%
State Street
4
State Street
Massachusetts
$248M +$6.66M +141,148 +3%
Renaissance Technologies
5
Renaissance Technologies
New York
$235M +$61.2M +1,298,200 +39%
Norges Bank
6
Norges Bank
Norway
$205M -$196M -4,154,658 -51%
Prudential Financial
7
Prudential Financial
New Jersey
$202M -$20.6M -435,980 -10%
Millennium Management
8
Millennium Management
New York
$196M +$43.6M +923,455 +31%
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$179M +$121M +2,563,643 +265%
Two Sigma Advisers
10
Two Sigma Advisers
New York
$140M +$6.35M +134,659 +5%
AQR Capital Management
11
AQR Capital Management
Connecticut
$138M +$47.5M +1,007,507 +59%
Allianz Asset Management
12
Allianz Asset Management
Germany
$135M -$16.1M -340,273 -11%
TCIM
13
TIAA CREF Investment Management
New York
$134M +$40.8M +865,037 +48%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$120M +$8.19M +173,523 +8%
JP Morgan Chase
15
JP Morgan Chase
New York
$111M +$11.1M +234,705 +12%
Goldman Sachs
16
Goldman Sachs
New York
$94M +$2.66M +56,307 +3%
Two Sigma Investments
17
Two Sigma Investments
New York
$89.5M +$20.1M +425,388 +32%
Northern Trust
18
Northern Trust
Illinois
$83.8M +$1.91M +40,547 +3%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$78.2M -$2.45M -51,911 -3%
GCM
20
Gates Capital Management
New York
$76.2M -$13.3M -282,671 -16%
GC
21
Greenlight Capital
New York
$75.2M -$99.9M -2,118,070 -59%
Invesco
22
Invesco
Georgia
$70.6M -$2.06M -43,677 -3%
AL
23
AJO LP
Pennsylvania
$63M -$3.24M -68,655 -5%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$60.1M -$19.4M -411,882 -26%
CCI
25
Columbus Circle Investors
$51.7M +$30.6M +648,200 +173%

CC Hedge Fund Activity: Q3 2017 in Review

499 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2017, worth a combined $7.18B — up 32% from $5.42B a quarter earlier.

Buyers outnumbered sellers: 84 funds opened new CC positions and 40 closed out — a net gain of 44 holders — while 131 added to existing stakes and 173 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $121M. The largest seller was Norges Bank, cutting an estimated $196M.

  • 499 institutional investors held Chemours (CC) as of Q3 2017, up from 462 in Q2 2017.
  • Funds reported $7.18B of Chemours stock for Q3 2017, up 32% quarter-over-quarter.
  • 84 funds opened new Chemours positions in Q3 2017 and 40 closed out, a net change of +44 holders.
  • The largest Chemours buyer in Q3 2017 was Adage Capital Partners, an estimated $121M added.
  • The largest Chemours seller in Q3 2017 was Norges Bank, an estimated $196M sold.

Based on aggregated 13F filings for Q3 2017.